Helicobacter pylori (H. pylori)<\/i> is a cork-screw-spiral-like gram-negative bacterium that has adapted to grow in the human stomach. The prevalence of H. pylori infection worldwide is approximately 66%, and in developing countries, it is as high as 80% \u2013 90%. The testing and treatment of H. pylori<\/i> is very important as it has been estimated that up to 20% of people infected with H. pylori<\/i> will develop ulcers which may lead to specific cancers. MP Diagnostics ASSURE H. pylori<\/i> Rapid Test and Helico Blot 2.1 Western Blot incorporate a unique marker, CIM, which is used to detect the current infection of H. pylori<\/i> bacteria. CIM stands for Current Infection Marker which is actually a H. pylori<\/i>-specific protein. The nucleotide sequence of the CIM antigen is homologous to a conserved secreted protein. This protein has been found to be highly immunogenic for detection of H. pylori<\/i> infected patients with high Positive Predictive Value of >90%. It has been coined as Current Infection Marker because IgG antibodies for CIM have been found in patients with active H. pylori<\/i> infection. These patients are confirmed to have active H. pylori<\/i> infection by two or more active infection diagnostic tests such as rapid urease test, culture, histology, and Urea Breath Test. With CIM-based products, no additional tests are needed for detecting current H. pylori<\/i> infection.
\n
\nSupplier:<\/strong> MP Biomedicals- Diagnostics
\nWebsite:<\/strong> <\/a><\/p>\n
Mail the supplier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"